Research Article

Clinical Course of Pregnant Women with Maternal Hydronephrosis: Retrospective Clinical Study

Volume: 23 Number: 2 August 30, 2021
EN TR

Clinical Course of Pregnant Women with Maternal Hydronephrosis: Retrospective Clinical Study

Abstract

Aim: The study aims to investigate the clinical course of symptomatic physiological hydronephrosis in pregnant women and the results of treatment in patients required treatment. Material and Methods: A hundred and two consecutive pregnant women who presented with clinical signs and symptoms related to the upper urinary system were included in the study. Renal ultrasonography, urinalysis, serum creatinine levels, white blood cell count, and urine culture were done in all patients at the first visit and repeated at least once a month until 1 month after delivery. In patients with acute pyelonephritis, urinalysis was repeated every 3 days until white blood cell count, erythrocyte sedimentation rate and C-reactive protein levels normalized; urine culture and kidney ultrasonography were performed monthly until 1 month after delivery. Conservative measures (positioning, analgesia, antibiotics) were used in all patients with symptomatic physiological hydronephrosis. If the patient's condition was resistant to medical treatment and the degree of hydronephrosis was increased, drainage was performed by inserting a double J stent into the ureter. Results: Conservative treatments were successful in 98 (96.1%) of 102 patients, but 4 (3.9%) had signs and symptoms of acute pyelonephritis progressing to urosepsis. Antibiotics were continued in patients who developed pyelonephritis, symptoms regressed rapidly, signs of kidney infection returned to normal. Follow-up pregnancies ended with normal vaginal delivery. Conclusion: Symptomatic hydronephrosis in pregnancy can be treated conservatively, should be treated carefully and patients should be followed up. However, ureteral double-J stenting is an effective and safe treatment method in patients with resistant symptoms.

Keywords

References

  1. Ercil H, Arslan B, Ortoglu F, Alma E, Unal U, Deniz M, et al. Conservative/surgical treatment predictors of maternal hydronephrosis: results of a single-center retrospective non-randomized non-controlled observational study. Int Urol Nephrol. 2017;49(8):1347-52.
  2. Coban S, Biyik I, Ustunyurt E, Keles I, Guzelsoy M, Demirci H. Is there a relationship between the grade of maternal hydronephrosis and birth weight of the babies? J Matern Fetal Neonatal Med. 2015;28(9):1053-6.
  3. Watson WJ, Brost BC. Maternal hydronephrosis in pregnancy: poor association with symptoms of flank pain. Am J Perinatol. 2006;23(8):463-6.
  4. Farr A, Ott J, Kueronya V, Margreiter M, Javadli E, Einig S, et al. The association between maternal hydronephrosis and acute flank pain during pregnancy: a prospective pilot-study. J Matern Fetal Neonatal Med. 2017;30(20):2417-21.
  5. Choi CI, Yu YD, Park DS. Ureteral stent insertion in the management of renal colic during pregnancy. Chonnam Med J. 2016;52(2):123-7.
  6. Tsai YL, Seow KM, Yieh CH, Chong KM, Hwang JL, Lin YH, et al. Comparative study of conservative and surgical management for symptomatic moderate and severe hydronephrosis in pregnancy: a prospective randomized study. Acta Obstet Gynecol Scand. 2007;86(9):1047-50.
  7. Zwergel T, Lindenmeir T, Wullich B. Management of acute hydronephrosis in pregnancy by ureteral stenting. Eur Urol. 1996;29(3):292-7.
  8. Puskar D, Balagović I, Filipović A, Knezović N, Kopjar M, Huis M, et al. Symptomatic physiologic hydronephrosis in pregnancy: incidence, complications and treatment. Eur Urol. 2001;39(3):260-3.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

August 30, 2021

Submission Date

April 15, 2021

Acceptance Date

July 9, 2021

Published in Issue

Year 2021 Volume: 23 Number: 2

APA
Saylam, B., Efesoy, A., & Erdem, E. (2021). Clinical Course of Pregnant Women with Maternal Hydronephrosis: Retrospective Clinical Study. Duzce Medical Journal, 23(2), 170-173. https://doi.org/10.18678/dtfd.917116
AMA
1.Saylam B, Efesoy A, Erdem E. Clinical Course of Pregnant Women with Maternal Hydronephrosis: Retrospective Clinical Study. Duzce Med J. 2021;23(2):170-173. doi:10.18678/dtfd.917116
Chicago
Saylam, Barış, Aysun Efesoy, and Erim Erdem. 2021. “Clinical Course of Pregnant Women With Maternal Hydronephrosis: Retrospective Clinical Study”. Duzce Medical Journal 23 (2): 170-73. https://doi.org/10.18678/dtfd.917116.
EndNote
Saylam B, Efesoy A, Erdem E (August 1, 2021) Clinical Course of Pregnant Women with Maternal Hydronephrosis: Retrospective Clinical Study. Duzce Medical Journal 23 2 170–173.
IEEE
[1]B. Saylam, A. Efesoy, and E. Erdem, “Clinical Course of Pregnant Women with Maternal Hydronephrosis: Retrospective Clinical Study”, Duzce Med J, vol. 23, no. 2, pp. 170–173, Aug. 2021, doi: 10.18678/dtfd.917116.
ISNAD
Saylam, Barış - Efesoy, Aysun - Erdem, Erim. “Clinical Course of Pregnant Women With Maternal Hydronephrosis: Retrospective Clinical Study”. Duzce Medical Journal 23/2 (August 1, 2021): 170-173. https://doi.org/10.18678/dtfd.917116.
JAMA
1.Saylam B, Efesoy A, Erdem E. Clinical Course of Pregnant Women with Maternal Hydronephrosis: Retrospective Clinical Study. Duzce Med J. 2021;23:170–173.
MLA
Saylam, Barış, et al. “Clinical Course of Pregnant Women With Maternal Hydronephrosis: Retrospective Clinical Study”. Duzce Medical Journal, vol. 23, no. 2, Aug. 2021, pp. 170-3, doi:10.18678/dtfd.917116.
Vancouver
1.Barış Saylam, Aysun Efesoy, Erim Erdem. Clinical Course of Pregnant Women with Maternal Hydronephrosis: Retrospective Clinical Study. Duzce Med J. 2021 Aug. 1;23(2):170-3. doi:10.18678/dtfd.917116

Cited By